Excelsior Biopharma (Taiwan) Market Value
| 6496 Stock | TWD 32.15 0.35 1.10% |
| Symbol | Excelsior |
Excelsior Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Excelsior Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Excelsior Biopharma.
| 12/25/2024 |
| 01/24/2025 |
If you would invest 0.00 in Excelsior Biopharma on December 25, 2024 and sell it all today you would earn a total of 0.00 from holding Excelsior Biopharma or generate 0.0% return on investment in Excelsior Biopharma over 30 days. Excelsior Biopharma is related to or competes with De Licacy, Acelon Chemicals, Allied Industrial, Song Ho, Chialin Precision, Sunspring Metal, and Wha Yu. More
Excelsior Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Excelsior Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Excelsior Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.48 | |||
| Information Ratio | 0.037 | |||
| Maximum Drawdown | 17.37 | |||
| Value At Risk | (2.51) | |||
| Potential Upside | 2.88 |
Excelsior Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Excelsior Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Excelsior Biopharma's standard deviation. In reality, there are many statistical measures that can use Excelsior Biopharma historical prices to predict the future Excelsior Biopharma's volatility.| Risk Adjusted Performance | 0.0561 | |||
| Jensen Alpha | 0.1048 | |||
| Total Risk Alpha | 0.021 | |||
| Sortino Ratio | 0.0332 | |||
| Treynor Ratio | 0.2976 |
Excelsior Biopharma Backtested Returns
At this stage we consider Excelsior Stock to be very steady. Excelsior Biopharma secures Sharpe Ratio (or Efficiency) of 0.0587, which denotes the company had a 0.0587 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Excelsior Biopharma, which you can use to evaluate the volatility of the firm. Please confirm Excelsior Biopharma's Downside Deviation of 2.48, mean deviation of 1.11, and Semi Deviation of 1.69 to check if the risk estimate we provide is consistent with the expected return of 0.13%. Excelsior Biopharma has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.4, which means possible diversification benefits within a given portfolio. As returns on the market increase, Excelsior Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Excelsior Biopharma is expected to be smaller as well. Excelsior Biopharma right now shows a risk of 2.22%. Please confirm Excelsior Biopharma downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if Excelsior Biopharma will be following its price patterns.
Auto-correlation | -0.31 |
Poor reverse predictability
Excelsior Biopharma has poor reverse predictability. Overlapping area represents the amount of predictability between Excelsior Biopharma time series from 25th of December 2024 to 9th of January 2025 and 9th of January 2025 to 24th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Excelsior Biopharma price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Excelsior Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.47 |
Excelsior Biopharma lagged returns against current returns
Autocorrelation, which is Excelsior Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Excelsior Biopharma's stock expected returns. We can calculate the autocorrelation of Excelsior Biopharma returns to help us make a trade decision. For example, suppose you find that Excelsior Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Excelsior Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Excelsior Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Excelsior Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Excelsior Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Excelsior Biopharma Lagged Returns
When evaluating Excelsior Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Excelsior Biopharma stock have on its future price. Excelsior Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Excelsior Biopharma autocorrelation shows the relationship between Excelsior Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Excelsior Biopharma.
Regressed Prices |
| Timeline |
Pair Trading with Excelsior Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Excelsior Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Excelsior Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against Excelsior Stock
The ability to find closely correlated positions to Excelsior Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Excelsior Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Excelsior Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Excelsior Biopharma to buy it.
The correlation of Excelsior Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Excelsior Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Excelsior Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Excelsior Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Excelsior Stock Analysis
When running Excelsior Biopharma's price analysis, check to measure Excelsior Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Excelsior Biopharma is operating at the current time. Most of Excelsior Biopharma's value examination focuses on studying past and present price action to predict the probability of Excelsior Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Excelsior Biopharma's price. Additionally, you may evaluate how the addition of Excelsior Biopharma to your portfolios can decrease your overall portfolio volatility.